89
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer

, , , ORCID Icon, , & show all
Pages 8651-8661 | Published online: 18 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Georg Schlachtenberger, Fabian Doerr, Hruy Menghesha, Andres Amorin, Katja Hoepker, Lars Hagmeyer, Thorsten Wahlers, Khosro Hekmat & Matthias B. Heldwein. (2023) Prognostic impact of lymph node spreading pattern in N2 NSCLC patients. Expert Review of Anticancer Therapy 23:3, pages 319-326.
Read now

Articles from other publishers (1)

Yuanyuan Cheng, Zhe Ye, Yanru Xie, Xuedan Du, Siqi Song, Xiaobo Ding, Chuchu Lin, Bin Wang, Wenfeng Li & Chunhong Zhang. (2023) Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer. Clinical and Translational Oncology.
Crossref